- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07672457
Substance Use Prevention for Recently Displaced Adults - SUPRA (R33) RCT (SUPRA RCT R33)
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The war in Ukraine has provoked the world's current largest humanitarian displacement: since February 2022, over 13 million people, i.e., one-third of Ukrainians, have been forced to leave their homes, resulting in nearly 6 million internally displaced persons (IDPs). War and humanitarian emergencies may exacerbate substance use, but the incidence and prevalence of unhealthy substance use in humanitarian settings, including Ukraine, are currently largely unknown. This lack of data limits the ability to tailor targeted, effective preventive substance use interventions for these mobile populations. Addressing this knowledge gap is an immense priority for Ukraine, where rates of substance use were high even prior to the Russian invasion in February 2022, and in other settings hosting large populations of IDPs, including the United States.
To determine the feasibility, acceptability, and preliminary effectiveness of the intervention among IDPs, a RCT to evaluate implementation and substance use outcomes associated with the intervention at 1 and 6 months.
The investigators hypothesize that an ACT-based intervention delivered in a humanitarian context will help displaced persons in Ukraine build skills to manage stress and prevent or reduce substance use behaviors, ultimately mitigating the onset of substance use disorders.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Karsten Lunze, MD DrPH MPH
- Telefonnummer: 617-414-6933
- E-Mail: lunze@bu.edu
Studieren Sie die Kontaktsicherung
- Name: Kimberly Hook, PhD MA
- E-Mail: kmhook@hsph.harvard.edu
Studienorte
-
-
-
Kyiv, Ukraine
- Alliance for Public Health
-
Kontakt:
- Pavlo Smyrnov
- Telefonnummer: +380 44 490-5485
- E-Mail: Smyrnov@aph.org.ua
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Age 18 or over
- Have been displaced at least once due to Anti-Terrorist Operation (ATO) or full-scale invasion since 2014
- Self-reported use of at least one substance other than alcohol and tobacco within the past 3 months
- Ability to provide informed consent and speak Ukrainian or Russian
Exclusion Criteria:
- Self-reported diagnosis of a substance use disorder
- Inability to provide informed consent
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: ACT Therapy
Participants randomized to this group will receive the ACT intervention
|
The ACT group intervention will involve a mixture of didactic instruction, discussion, and experiential activities.
ACT will help internally displaced persons to manage stress and prevent or reduce substance use behaviors, ultimately mitigating the onset of substance use disorders.
|
|
Aktiver Komparator: Attention Control
Participants in the control group will receive minimally enhanced usual care to receive treatment as usual enhanced by a health information group session.
|
Usual care will be minimally enhanced by providing participants with an educational information session that provides information on health promotion.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Feasibility of the ACT Intervention
Zeitfenster: 1 month and 6 months
|
Feasibility will be assessed using the 14-item feasibility subscales of the Applied Mental Health Research Group Implementation Measure (AMHR-IM).
Each item is rated on a 4-point scale where "0" means "not at all" and "3" means "a lot".
The overall Feasibility score is calculated as the mean (average) across all 14 completed items, where higher scores (closer to 3) reflect a higher level of perceived feasibility of the intervention.
|
1 month and 6 months
|
|
Acceptability of the ACT Intervention
Zeitfenster: 1 month and 6 months
|
Acceptability will be assessed using the 17-item acceptability subscales of the Applied Mental Health Research Group Implementation Measure (AMHR-IM).
Each item is rated on a 4-point Likert scale where "0" means "not at all" and "3" means "a lot".
The overall Acceptability score is calculated as the mean (average) across all 17 completed items, where higher scores (closer to 3) reflect a higher level of perceived acceptability of the intervention.
|
1 month and 6 months
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Karsten Lunze, MD DrPH MPH, Boston University Chobanian & Avedisian School of Medicine
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- H-46965
- R33DA059856 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .